The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter]

Wardoyo S, Fadillah MA, Hamtini

Breast Cancer: Targets and Therapy 2023, 15:953-954

Published Date: 19 December 2023